• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1991 年至 2010 年对 1112 例产前样本进行脆性 X 分析。

Fragile X analysis of 1112 prenatal samples from 1991 to 2010.

机构信息

Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA.

出版信息

Prenat Diagn. 2011 Oct;31(10):925-31. doi: 10.1002/pd.2815. Epub 2011 Jun 30.

DOI:10.1002/pd.2815
PMID:21717484
Abstract

OBJECTIVE

To determine risks of expansion for normal, intermediate, and premutation FMR1 CGG repeats.

METHODS

PCR was used to compare the FMR1 alleles in prenatal (chorionic villi and amniocytes) and parental samples collected from 1991 to 2010. Prenatal diagnoses were confirmed by Southern analysis.

RESULTS

Fragile X analysis of 1112 pregnancies identified 558 normal, 106 intermediate, 216 premutation, and 232 full mutation fetuses. Of 509 maternal, intermediate, and premutation alleles, 350 (68.7%) were unstable on transmission with expansions ranging from one repeat to the full mutation. The smallest premutation alleles expanding to the full mutation were in mothers with 65 and 66 repeats. Transmissions from women with or without a family history of fragile X suggested greater instability in women from families that included full mutation expansions.

CONCLUSIONS

The maternal transmissions of alleles with 55 to 59 CGG repeats summarized here indicate that the risk for expansion to full mutation is substantially less than previous estimates for this size category. Most premutation alleles with no family history of fragile X exhibited less instability than those with a history of fragile X. Thus, lower risk estimates for full mutation expansion may be appropriate for women newly identified as premutation carriers through routine screening.

摘要

目的

确定正常、中间和前突变 FMR1 CGG 重复的扩展风险。

方法

PCR 用于比较 1991 年至 2010 年间收集的产前(绒毛膜和羊水细胞)和父母样本中的 FMR1 等位基因。产前诊断通过 Southern 分析确认。

结果

对 1112 例妊娠进行脆性 X 分析,确定了 558 例正常、106 例中间、216 例前突变和 232 例全突变胎儿。在 509 个母亲、中间和前突变等位基因中,有 350 个(68.7%)在传递过程中不稳定,重复数从一个增加到全突变。扩展到全突变的最小前突变等位基因存在于重复数为 65 和 66 的母亲中。来自脆性 X 家族史有或无的女性的传递表明,包括全突变扩展的家族中的女性更不稳定。

结论

这里总结的 55 至 59 个 CGG 重复的母体等位基因传递表明,扩展到全突变的风险明显低于之前对该大小类别的估计。大多数没有脆性 X 家族史的前突变等位基因的不稳定性低于有脆性 X 家族史的等位基因。因此,对于通过常规筛查新发现为前突变携带者的女性,全突变扩展的风险估计可能较低。

相似文献

1
Fragile X analysis of 1112 prenatal samples from 1991 to 2010.1991 年至 2010 年对 1112 例产前样本进行脆性 X 分析。
Prenat Diagn. 2011 Oct;31(10):925-31. doi: 10.1002/pd.2815. Epub 2011 Jun 30.
2
Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.脆性X等位基因的患病率与不稳定性:对开展脆性X产前诊断的意义
Obstet Gynecol. 2008 Mar;111(3):596-601. doi: 10.1097/AOG.0b013e318163be0b.
3
Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population.在一个来自普通人群的 24449 对母婴前瞻性样本中,对 FMR1 等位基因进行筛查和不稳定性分析。
Clin Genet. 2009 Dec;76(6):511-23. doi: 10.1111/j.1399-0004.2009.01237.x. Epub 2009 Oct 23.
4
Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.具有前突变或中间等位基因的女性中脆性X CGG重复序列的扩增。
Am J Hum Genet. 2003 Feb;72(2):454-64. doi: 10.1086/367713. Epub 2003 Jan 14.
5
An assessment of screening strategies for fragile X syndrome in the UK.英国脆性X综合征筛查策略评估
Health Technol Assess. 2001;5(7):1-95. doi: 10.3310/hta5070.
6
Analysis of CGG variation through 642 meioses in Fragile X families.通过对脆性X综合征家系中的642次减数分裂进行分析,研究CGG变异情况。
Mol Hum Reprod. 2004 Oct;10(10):773-6. doi: 10.1093/molehr/gah102. Epub 2004 Aug 20.
7
Reliable and sensitive detection of fragile X (expanded) alleles in clinical prenatal DNA samples with a fast turnaround time.可靠且灵敏地检测临床产前 DNA 样本中的脆性 X(扩展)等位基因,检测周转时间短。
J Mol Diagn. 2012 Nov;14(6):560-8. doi: 10.1016/j.jmoldx.2012.05.003. Epub 2012 Aug 23.
8
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.通过常规产前筛查检测出的脆性X前突变携带者的扩增风险低于来自已知脆性X家族的携带者。
Genet Test. 2000;4(3):289-92. doi: 10.1089/10906570050501524.
9
Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.用于扩增FMR1基因的人类脆性X智力低下1型聚合酶链反应试剂的评估:在临床诊断实验室中的测试
Genet Test Mol Biomarkers. 2012 Mar;16(3):187-92. doi: 10.1089/gtmb.2011.0128. Epub 2011 Oct 12.
10
Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.运用稳健的FMR1聚合酶链反应分析法在中国产科人群中鉴定脆性X前突变携带者:对筛查和产前诊断的意义
Hong Kong Med J. 2017 Apr;23(2):110-6. doi: 10.12809/hkmj164936. Epub 2017 Mar 3.

引用本文的文献

1
Prevalence and implications of fragile X premutation screening in Thailand.脆性 X 前突变筛查在泰国的流行情况及其意义。
Sci Rep. 2024 Nov 1;14(1):26257. doi: 10.1038/s41598-024-77762-3.
2
Primary ovarian insufficiency: update on clinical and genetic findings.原发性卵巢功能不全:临床与遗传学研究进展。
Front Endocrinol (Lausanne). 2024 Sep 26;15:1464803. doi: 10.3389/fendo.2024.1464803. eCollection 2024.
3
Population-based FMR1 carrier screening among reproductive women.针对育龄妇女开展基于人群的脆性X智力低下基因1(FMR1)携带者筛查。
J Assist Reprod Genet. 2024 Nov;41(11):3237-3243. doi: 10.1007/s10815-024-03242-2. Epub 2024 Sep 25.
4
Sequence composition changes in short tandem repeats: heterogeneity, detection, mechanisms and clinical implications.短串联重复序列的序列组成变化:异质性、检测、机制和临床意义。
Nat Rev Genet. 2024 Jul;25(7):476-499. doi: 10.1038/s41576-024-00696-z. Epub 2024 Mar 11.
5
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.囊性纤维化、脆性 X 综合征、血红蛋白病和地中海贫血、脊髓性肌萎缩症携带者筛查计划:一项卫生技术评估。
Ont Health Technol Assess Ser. 2023 Aug 10;23(4):1-398. eCollection 2023.
6
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).神经发育障碍的遗传和代谢研究:加拿大医学遗传学家学院(CCMG)的立场声明。
J Med Genet. 2023 Jun;60(6):523-532. doi: 10.1136/jmg-2022-108962. Epub 2023 Feb 23.
7
Screening for CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder.对泰国自闭症谱系障碍患者的 CGG 重复扩展进行筛查。
Biomed Res Int. 2021 Dec 8;2021:4359308. doi: 10.1155/2021/4359308. eCollection 2021.
8
Frequency of FMR1 Premutation Alleles in Patients with Undiagnosed Cerebellar Ataxia and Multiple System Atrophy in the Japanese Population.在日本人群中,未诊断出的小脑共济失调和多系统萎缩患者中 FMR1 前突变等位基因的频率。
Cerebellum. 2022 Dec;21(6):954-962. doi: 10.1007/s12311-021-01329-5. Epub 2021 Nov 29.
9
Genetic counseling as preventive intervention: toward individual specification of transgenerational autism risk.遗传咨询作为预防干预措施:朝向跨代自闭症风险的个体化特异性。
J Neurodev Disord. 2021 Sep 16;13(1):39. doi: 10.1186/s11689-021-09389-8.
10
The Impact of X-Chromosome Inactivation on Phenotypic Expression of X-Linked Neurodevelopmental Disorders.X染色体失活对X连锁神经发育障碍表型表达的影响。
Brain Sci. 2021 Jul 9;11(7):904. doi: 10.3390/brainsci11070904.